These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 3728562

  • 21. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
    Gajko-Galicka A.
    Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
    [Abstract] [Full Text] [Related]

  • 22. Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: influence of age.
    Fedarko NS, D'Avis P, Frazier CR, Burrill MJ, Fergusson V, Tayback M, Sponseller PD, Shapiro JR.
    J Bone Miner Res; 1995 Nov; 10(11):1705-12. PubMed ID: 8592947
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
    Cabral WA, Makareeva E, Letocha AD, Scribanu N, Fertala A, Steplewski A, Keene DR, Persikov AV, Leikin S, Marini JC.
    Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
    [Abstract] [Full Text] [Related]

  • 26. Biochemical analysis of callus tissue in osteogenesis imperfecta type IV. Evidence for transient overmodification in collagen types I and III.
    Brenner RE, Vetter U, Nerlich A, Wörsdorfer O, Teller WM, Müller PK.
    J Clin Invest; 1989 Sep; 84(3):915-21. PubMed ID: 2760218
    [Abstract] [Full Text] [Related]

  • 27. G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix.
    Cabral WA, Chernoff EJ, Marini JC.
    Mol Genet Metab; 2001 Apr; 72(4):326-35. PubMed ID: 11286507
    [Abstract] [Full Text] [Related]

  • 28. Altered processing of alpha (I) collagen in a case of lethal osteogenesis imperfecta.
    Piccirillo A, Delfino M, Descalzi Cancedda F, Cancedda R.
    Ital J Biochem; 1986 Apr; 35(5):321-7. PubMed ID: 3804700
    [Abstract] [Full Text] [Related]

  • 29. Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model.
    Kuznetsova NV, Forlino A, Cabral WA, Marini JC, Leikin S.
    Matrix Biol; 2004 May; 23(2):101-12. PubMed ID: 15246109
    [Abstract] [Full Text] [Related]

  • 30. Incorporation of type I collagen molecules that contain a mutant alpha 2(I) chain (Gly580-->Asp) into bone matrix in a lethal case of osteogenesis imperfecta.
    Niyibizi C, Bonadio J, Byers PH, Eyre DR.
    J Biol Chem; 1992 Nov 15; 267(32):23108-12. PubMed ID: 1385413
    [Abstract] [Full Text] [Related]

  • 31. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H.
    Clin Calcium; 2009 Aug 15; 19(8):1142-7. PubMed ID: 19638698
    [Abstract] [Full Text] [Related]

  • 32. [Osteogenesis imperfecta: contribution to pathobiochemistry].
    Pontz BF, Müller PK.
    Padiatr Padol; 1984 Aug 15; 19(4):365-70. PubMed ID: 6504544
    [Abstract] [Full Text] [Related]

  • 33. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix.
    Mundlos S, Chan D, Weng YM, Sillence DO, Cole WG, Bateman JF.
    J Biol Chem; 1996 Aug 30; 271(35):21068-74. PubMed ID: 8702873
    [Abstract] [Full Text] [Related]

  • 34. Isolation and characterization of bone cells from a patient with osteogenesis imperfecta type 1b.
    Puzas JE, Brand JS, Jackman KV.
    Bone Miner; 1986 Oct 30; 1(5):373-82. PubMed ID: 2849487
    [Abstract] [Full Text] [Related]

  • 35. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
    Bateman JF, Mascara T, Chan D, Cole WG.
    Biochem J; 1984 Jan 01; 217(1):103-15. PubMed ID: 6421277
    [Abstract] [Full Text] [Related]

  • 36. Deletions and duplications of Gly-Xaa-Yaa triplet repeats in the triple helical domains of type I collagen chains disrupt helix formation and result in several types of osteogenesis imperfecta.
    Pace JM, Atkinson M, Willing MC, Wallis G, Byers PH.
    Hum Mutat; 2001 Oct 01; 18(4):319-26. PubMed ID: 11668615
    [Abstract] [Full Text] [Related]

  • 37. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV.
    Jensen BL, Lund AM.
    J Craniofac Genet Dev Biol; 1997 Oct 01; 17(3):121-32. PubMed ID: 9338855
    [Abstract] [Full Text] [Related]

  • 38. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site.
    Radmer RJ, Klein TE.
    Biochemistry; 2004 May 11; 43(18):5314-23. PubMed ID: 15122897
    [Abstract] [Full Text] [Related]

  • 39. Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta.
    Tenni R, Valli M, Rossi A, Cetta G.
    Am J Med Genet; 1993 Jan 15; 45(2):252-6. PubMed ID: 8456811
    [Abstract] [Full Text] [Related]

  • 40. Osteogenesis imperfecta congenita: evidence for a generalized molecular disorder of collagen.
    Trelstad RL, Rubin D, Gross J.
    Lab Invest; 1977 May 15; 36(5):501-8. PubMed ID: 865078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.